Physician profile
Robert Girling
NPI 1356661904
$81,332.53
in general payments reported to CMS, 2019-2025
12 companies · $23K in 2025
The $23K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $255 · 2021: $1,317 · 2022: $1,352 · 2023: $900 · 2024: $25K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $18K · Food and Beverage: $4,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,950.00 |
| Travel and Lodging | $17,541.16 |
| Food and Beverage | $4,693.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corentec America INC | $47,821.35 | 2023-2025 | Corentec |
| Ortho Development Corporation | $31,780.07 | 2019-2023 | |
| Medinc of Texas | $1,224.54 | 2021-2023 | |
| Corin USA | $207.23 | 2019 | |
| Depuy Synthes Sales INC. | $98.52 | 2019-2022 | |
| Sanara Medtech INC. | $83.82 | 2020 | |
| Bioventus LLC | $25.70 | 2020 | |
| Sanofi-Aventis U.S. LLC | $24.61 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $22.92 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.12 | 2024 | Exparel |
| Pacira Therapeutics, INC. | $12.54 | 2019 | |
| Orthofix Medical, INC. | $11.11 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Girling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.